Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |